https://doi.org/10.5812/jjm.91181

Genotyping of Causative Agents of Cutaneous Leishmaniasis in Patients Using PCR-RFLP Method in Dasht-e-Azadegan County, Southwest of Iran, in 2016

authors:

avatar Sattar Khazael 1 , 2 , avatar Jasem Saki ORCID 2 , avatar Reza Arjmand ORCID 1 , 2 , *

Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Parasitology Department, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Jundishapur Journal of Microbiology: Vol.12, issue 9; e91181
published online: September 21, 2019
article type: Research Article
received: March 3, 2019
revised: March 5, 2019
accepted: July 25, 2019

How To Cite Khazael S, Saki J, Arjmand R. Genotyping of Causative Agents of Cutaneous Leishmaniasis in Patients Using PCR-RFLP Method in Dasht-e-Azadegan County, Southwest of Iran, in 2016. Jundishapur J Microbiol. 2019;12(9):e91181. https://doi.org/10.5812/jjm.91181.

Abstract

Background:

As a neglected disease, cutaneous leishmaniasis renders considerable incidence rates. Eastern Mediterranean countries such as Iran are endemic for this infection.

Objectives:

Herein, we determined the species/strains of the causative agents of cutaneous leishmaniasis in Dasht-e-Azadegan, Khuzestan, Iran, using PCR-RFLP in 2016.

Methods:

We microscopically examined 80 smear slides from suspected patients referring to health centers of the city. After DNA extraction from slide materials, the amplification of the ITS1 fragment was done using the LITSR and L5.8S primer pair for Leishmania molecular detection. Subsequently, HaeIII (species level), TaqI (strain level), DpnI, and HpaII (mutation analysis) digestion was exerted based on the RFLP method.

Results:

Microscopic examination revealed the amastigote forms of Leishmania in all 80 samples. A 350 bp band was amplified by ITS1-PCR, which confirmed the infection at the molecular level. Following HaeIII digestion, 150 and 200 bp fragments were produced indicating Leishmania major. Also, TaqI digestion rendered 130 and 200 bp bands suggesting the A1 strain. Moreover, no mutations were detected in the genome of the identified L. major A1 strains by DpnI (140 and 200 bp bands) and HpaII (no digestion) digestion.

Conclusions:

The genotypic heterogeneity of Leishmania species is of utmost importance for better treatment choices, appropriate diagnosis, and preventive measures. Future work in the area should address the parasite strains in alternative vector/reservoir hosts.

1. Background

Leishmaniasis are ancient neglected tropical diseases (NTDs) caused by over 21 species of intracellular Leishmania parasites with sand flies as vectors and a broad range of clinical presentations comprising simple, diffuse and mucocutaneous leishmaniasis, as well as the visceral disease (1). Approximately, 100 countries are located in leishmaniasis endemic regions and 350 million people are at risk of infection (2). Cutaneous leishmaniasis and visceral disease are two important manifestations of leishmaniasis with the incidence of 0.7 - 1.2 and 0.2 - 0.4 million new cases per year, respectively (3).

Cutaneous leishmaniasis is most highlighted in 10 nations including Columbia, Brazil, Costa Rica, Peru, Iran, Syria, Afghanistan, Algeria, Ethiopia, and North Sudan (2). A number of risk factors such as migration to endemic areas, urbanization with the increased risk of vector localization and man-made manipulation in the environment are involved in the occurrence and distribution of cutaneous leishmaniasis (4). Countries located in the Eastern Mediterranean territory such as Iran possess appropriate conditions for cutaneous leishmaniasis endemicity (5). Although neglected, it is estimated that 30.9 new cutaneous leishmaniasis cases per 100000 population occur in Iran, which is mostly highlighted in Isfahan and Fars provinces (3). After malaria, cutaneous leishmaniasis is the second most prevalent arthropod-borne disease in the country, representing as two major forms: (1) anthroponotic, dry, or urban leishmaniasis due to Leishmania tropica particularly in cities with high population density and daily immigrants and (2) zoonotic, wet, or rural leishmaniasis owing to L. major occurring in rustic areas with weak hygienic infrastructures and rodent species as reservoir hosts (3).

Routine parasitology examination for the diagnosis of cutaneous leishmaniasis is lesion sampling and observation of intracellular amastigote forms in macrophages. However, such a technique does not detect the exact species and/or strains of the parasite for better subsequent treatment options and prevention strategies (6). Hence, sophisticated molecular tests are recommended for species identification and detection of resistant isolates. The highly-conserved fragment of internal transcribed spacer-1 (ITS1) from ribosomal RNA (rRNA) is a classic genetic hallmark for phylogenetic categorization of closely-related species. The parasite species/strains and their likely mutant forms can be determined using restriction enzymes in polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in the ITS1 region (7, 8).

So far, several studies have been conducted on the genotyping of cutaneous leishmaniasis agents in various geographical areas of Iran. For instance, Kermanjani et al. proved all clinical isolates as L. major using HaeIII enzyme digestion, without strain and mutation analysis (9). Another genotyping study of clinical isolates in Isfahan and Bam by HaeIII and TaqI enzyme digestion showed the presence of LmA and LmB as L. major strains, while LtA and LtB were the specified strains of L. tropica (10). A considerable part of our knowledge of the genomic structure of cutaneous leishmaniasis species in Iran originates from studies performed in western/southwestern endemic foci. Previous studies carried out retrospective investigations, comparable culture, and mini-exon PCR, as well as PCR-RFLP for species determination, in this endemic territory (11-13).

2. Objectives

The current original study was accomplished to assess the molecular identification of cutaneous leishmaniasis species/strains with emphasis on possible mutations in clinical samples from suspected patients in Dasht-e-Azadegan county, Khuzestan, Southwestern Iran.

3. Methods

3.1. Study Population and Samples

In this study, 80 samples were obtained as slide smears from dermal lesions of suspected individuals referring to Dasht-e-Azadegan health centers, Southwest of Iran, in 2016 and confirmed by the centers. All specimens were accurately examined by Giemsa staining and light microscopy to observe amastigote forms of genus Leishmania and confirm cutaneous leishmaniasis.

3.2. DNA Extraction and PCR-RFLP Technique

Following washing the slides with PBS solution, the smear contents were scraped using a scalpel and transferred to a 1.5 mL microtube. After a second PBS washing, the GeNet Bio PrimePrep DNA extraction kit from tissue (Genet Bio, South Korea) was used for DNA extraction, based on the manufacturer’s protocol. Finally, the extracted DNA material was kept at -20°C for next use.

ITS1-PCR was applied using the LITSR (5-CTGGATCATTTTCCGATG-3) and L5.8S (5-TGATACCACTTATCGCACTT-3) primer pair to detect genus Leishmania in clinical isolates. For this aim, the 25 µL reaction mixture consisted of 1.5 mM MgCl2, 250 µM dNTPs, 1 U Taq DNA polymerase, and 10 pmol of each primer. The amplification process was done in a thermal cycler (Analytik Jena, Germany) in the following condition: initial denaturation at 95°C for 5 minutes, 35 cycles of denaturation at 94°C for 30 seconds, annealing at 55°C for 45 seconds, extension at 72°C for 45 seconds; and final extension at 72°C for 5 minutes. Following genus determination by PCR, species/strains were identified using the RFLP method (14). Accordingly, Leishmania species were discerned by HaeIII (Jena Bioscience, Germany) with 5 µL PCR product, 2.5 µL universal buffer, 1.5 µL enzyme, and 6 µL sterile deionized water.

Strains were distinguished by TaqI (Jena Bioscience, Germany) under the previous reaction condition. Moreover, DpnI (Thermo Fisher Scientific, USA) and HpaII (Jena Bioscience, Germany) were used for mutation analysis based on a reaction containing 6 µL PCR product, 2 µL universal buffer, 1 µL enzyme, and 7 µL sterile molecular-grade water. All mixtures were incubated at 37°C for 3 hours, except for the TaqI mixture that was incubated at 65°C for 3 hours. The 1.5% and 2% gel electrophoresis, followed by gel-doc monitoring, was applied for PCR and digestion products, respectively.

4. Results

The results of the microscopic examination indicated that all the 80 suspected slide smears collected in this study were confirmed as cutaneous leishmaniasis (Figure 1). The PCR technique demonstrated genus Leishmania in all specimens by representing a 350 bp band in accordance with the amplification of the ITS1 region (Figure 2). On the basis of HaeIII digestion, all samples showed 150 and 200 bp patterns, representing L. major species (Figure 3). Then, TaqI digestion rendered A1 strain of L. major (LmA1) with 130 and 200 bp band patterns (Figure 4). Mutation analysis was carried out by DpnI rendering 150 and 205 bp bands on PCR products (Figure 5). Moreover, the application of HpaII restriction enzyme caused no digestion; thus, no mutation was found in the ITS1 fragment of the isolated species.

Collected and Giemsa-stained smears indicating Leishmania amastigotes inside macrophages
Collected and Giemsa-stained smears indicating Leishmania amastigotes inside macrophages
Figure 1.

Collected and Giemsa-stained smears indicating Leishmania amastigotes inside macrophages

The amplified 350 bp bands of genus Leishmania, based on ITS1 fragment (M = marker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 7 = confirmed species of Leishmania)
The amplified 350 bp bands of genus Leishmania, based on ITS1 fragment (M = marker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 7 = confirmed species of Leishmania)
Figure 2.

The amplified 350 bp bands of genus Leishmania, based on ITS1 fragment (M = marker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 7 = confirmed species of Leishmania)

Digestion pattern using HaeIII (M = maker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 8 = 150 and 200 bp bands indicating Leishmania major)
Digestion pattern using HaeIII (M = maker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 8 = 150 and 200 bp bands indicating Leishmania major)
Figure 3.

Digestion pattern using HaeIII (M = maker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 8 = 150 and 200 bp bands indicating Leishmania major)

Digestion pattern using TaqI (M = marker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 8 = 130 and 200 bp bands suggesting Leishmania major A1 strain)
Digestion pattern using TaqI (M = marker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 8 = 130 and 200 bp bands suggesting Leishmania major A1 strain)
Figure 4.

Digestion pattern using TaqI (M = marker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 8 = 130 and 200 bp bands suggesting Leishmania major A1 strain)

Digestion pattern using DpnI (M = marker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 7 = 150 and 205 bp bands indicating no mutation)
Digestion pattern using DpnI (M = marker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 7 = 150 and 205 bp bands indicating no mutation)
Figure 5.

Digestion pattern using DpnI (M = marker; N = negative control; P = positive control (MHOM/64/IR/ER75); lanes 1 - 7 = 150 and 205 bp bands indicating no mutation)

5. Discussion

Leishmaniases are NTDs being endemic in 98 countries with over 350 million at-risk individuals. However, the occurrence of this infection is more than expected, due to under-diagnosis and/or non-compulsory infection report (6). Previously, the diagnosis was mostly based on traditional identification of lesions, as well as biological classification and isoenzyme typing. More recently, unprecedented nucleic acid-based techniques have facilitated the determination of Leishmania species/strains (8). The cutaneous disease due to Leishmania is the most prevalent form with an incidence rate of 20000 people annually in Iran (3). The current study aimed to address the species/strains of cutaneous leishmaniasis causative agents in people referring to the health centers of Dasht-e-Azadegan, Khuzestan province, using ITS1 PCR-RFLP in 2016. According to our findings, all samples showed a 350 bp band following ITS1-PCR, suggesting the molecular identification of genus Leishmania by the LITSR and L5.8S primer pair, which is consistent to Schonian et al research (15). Similarly, most studies in Iran have used this primer pair for the molecular detection of Leishmania (9, 16-20).

However, Mohammadiha et al. also used another ITS-specific primer pair yielding 800 - 850 bp PCR product (21). Next, species-dependent digestion using HaeIII produced 150 and 200 bp bands belonging to L. major. TaqI digestion revealed the A1 strain of L. major with digestion range of 120 to 210 bp. Moreover, no mutation site was determined in the obtained isolates by DpnI and HpaII digestion (22). Thus, all 80 samples isolated from suspected cases were identified by PCR-RFLP as LmA1 strains. In a similar investigation in Ilam province, Kermanjani et al. determined all microscopically confirmed clinical isolates as L. major; however, strains and mutations were not analyzed (9).

Many studies have documented L. major and other species in Iran and around the globe. For instance, Mahmoudzadeh-Niknam et al. found 341 Leishmania isolates including 58 L. tropica isolates and 283 L. major isolates in 11 geographical territories of Iran (23). Another study in Ahvaz, Dasht-e-Azadegan, Shush, Hendijan, and Ramhormoz revealed 14 Leishmania samples with 2 L. tropica isolates and 12 L. major isolates (13). According to Maraghi et al. 90% of the isolates from Shush county were L. major, while the remaining 10% were L. tropica (24). Based on previous studies in the province, it could be expected that L. major is the predominant species in the area. On the other hand, the traits of Tatera indica (reservoir) and Phlebotomus papatasi (vector) in the area, as well as various documentations from Khuzestan province, implicate this province along with Ilam and Bushehr provinces as the most highlighted regions for zoonotic cutaneous leishmaniasis in Iran (3, 25-27).

Mohammadiha et al. amplified ITS1 by MO-F and MO-R primers and made digestion using TaqI, yielding L. major (33 cases) and L. tropica (61 cases) in all clinical samples. They could also identify L. tropica (43 cases) and L. major (12 cases) using LITSR and L5.8S primers and HaeIII digestion (21). In addition, Doudi et al. used HaeIII and TaqI digestion in isolates from Isfahan and Bam, resulting in two L. major (LmA and LmB) and two L. tropica (LtA and LtB) strains, with digestion patterns similar to ours (140 and 210 bp); however, TaqI digestion generated 150 and 200 bp fragments, indicating a difference between central Iran isolates and isolates from Dasht-e-Azadegan (10). Tashakori et al. determined the genotype heterogeneity in zoonotic cutaneous leishmaniasis endemic areas of the country (Damghan, Dehloran, Dezful, and Kashan) and identified five strains (LmA, LmB, LmC, LmD, and LmE). Their results suggested that LmA is dispersed throughout Iran, especially in the southwestern part. LmC, LmD, and LmE were found only in Damghan and LmB was the exclusive isolate in Kashan (28).

Averting possible mutations, development of drug resistance, and subsequent generation of new strains would be dependent on the genetic persistence of a microorganism in reservoir hosts, thus preventing the impact of harsh environments. Consequently, LmA of L. major with rodent reservoir hosts naturally occurs in areas with L. major dominance. Furthermore, it is suggested that LmA is the most ancient strain with significant adaptive capabilities to conditions of new foci and other genotypes have deduced from LmA. On the contrary, anthroponotic L. tropica does not possess reservoirs; thereby, it is more exposed to hostile milieu (environmental, seasonal, treatments, etc.) and probable mutations in the genome. Hence, the formation of novel strains is more likely to occur in L. tropica than in L. major (8, 10, 29).

Previously, a number of molecular studies on the diagnosis of cutaneous leishmaniasis were done in the Southwestern endemic region, particularly Khuzestan province. In a comparative study by Khademvatan et al. in some parts of the province, 216 skin biopsies from cutaneous leishmaniasis patients were examined using microscopy, culture, and mini-exon PCR; the authors remarked that the molecular technique is the gold standard technique that could diagnose both L. major and L. tropica (11). Another molecular study used real-time PCR and melt-curve analysis by Kinetoplast DNA primers on 102 archived slides, emphasizing L. major as the predominant strain (93.75%), based on our results in the southwest of Iran (30). A nested-PCR approach was also performed on 146 clinical samples in four geographical regions of the province by Maraghi et al., again with L. major as the prevailed species (94.5%), followed by L. tropica (5.5%) (31). In addition, a mini-exon PCR-RFLP study was conducted on 14 clinical cutaneous lesions of suspected patients from a different region of the province; the results identified 12 cases as L. major and only two cases as L. tropica. The authors used EaeI and HaeIII, whereas they did not determine parasite strains, unlike to our study we did (13).

5.1. Conclusions

In total, our results obtained by the PCR-RFLP method showed leishmaniasis, in particular, due to L. major, is predominated in Dasht-e-Azadegan region, Khuzestan province, suggesting the importance of zoonotic cutaneous leishmaniasis in the west and southwest endemic foci particularly with the presence of rodent reservoir hosts in the Khuzestan plain. Hence, future preventive measures should be taken into account. It is also suggested that the species/strains of Leishmania parasites be identified in isolates from rodents and sand fly vectors dwelling the area.

Acknowledgements

References

  • 1.

    Steverding D. The history of leishmaniasis. Parasit Vectors. 2017;10(1):82. [PubMed ID: 28202044]. [PubMed Central ID: PMC5312593]. https://doi.org/10.1186/s13071-017-2028-5.

  • 2.

    Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5). e35671. [PubMed ID: 22693548]. [PubMed Central ID: PMC3365071]. https://doi.org/10.1371/journal.pone.0035671.

  • 3.

    Foroutan M, Khademvatan S, Majidiani H, Khalkhali H, Hedayati-Rad F, Khashaveh S, et al. Prevalence of Leishmania species in rodents: A systematic review and meta-analysis in Iran. Acta Trop. 2017;172:164-72. [PubMed ID: 28454881]. https://doi.org/10.1016/j.actatropica.2017.04.022.

  • 4.

    Khademvatan S, Adibpour N, Eskandari A, Rezaee S, Hashemitabar M, Rahim F. In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes. Exp Parasitol. 2013;135(2):208-16. [PubMed ID: 23872452]. https://doi.org/10.1016/j.exppara.2013.07.004.

  • 5.

    Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterranean region. Int J Antimicrob Agents. 2010;36 Suppl 1:S62-5. [PubMed ID: 20728317]. https://doi.org/10.1016/j.ijantimicag.2010.06.023.

  • 6.

    Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581-96. [PubMed ID: 17714672]. https://doi.org/10.1016/S1473-3099(07)70209-8.

  • 7.

    Parvizi P, Moradi G, Akbari G, Farahmand M, Ready PD, Piazak N, et al. PCR detection and sequencing of parasite ITS-rDNA gene from reservoirs host of zoonotic cutaneous leishmaniasis in central Iran. Parasitol Res. 2008;103(6):1273-8. [PubMed ID: 18791741]. https://doi.org/10.1007/s00436-008-1124-z.

  • 8.

    Tashakori M, Kuhls K, Al-Jawabreh A, Mauricio IL, Schonian G, Farajnia S, et al. Leishmania major: Genetic heterogeneity of Iranian isolates by single-strand conformation polymorphism and sequence analysis of ribosomal DNA internal transcribed spacer. Acta Trop. 2006;98(1):52-8. [PubMed ID: 16513079]. https://doi.org/10.1016/j.actatropica.2006.01.010.

  • 9.

    Kermanjani A, Akhlaghi L, Oormazdi H, Hadighi R. Isolation and identification of cutaneous leishmaniasis species by PCR-RFLP in Ilam province, the west of Iran. J Parasit Dis. 2017;41(1):175-9. [PubMed ID: 28316408]. [PubMed Central ID: PMC5339195]. https://doi.org/10.1007/s12639-016-0772-7.

  • 10.

    Doudi M, Hejazi SH, Razavi MR, Narimani M, Khanjani S, Eslami G. Comparative molecular epidemiology of Leishmania major and Leishmania tropica by PCR-RFLP technique in hyper endemic cities of Isfahan and Bam, Iran. Med Sci Monit. 2010;16(11):CR530-5. [PubMed ID: 20980956].

  • 11.

    Khademvatan S, Saki J, Maraghi S. Comparison of traditional methods and PCR for diagnosis of cutaneous leishmaniasis in South-West of Iran. Zahedan J Res Med Sci. 2012;14(8):1-5.

  • 12.

    Khademvatan S, Salmanzadeh S, Foroutan-Rad M, Bigdeli S, Hedayati-Rad F, Saki J, et al. Spatial distribution and epidemiological features of cutaneous leishmaniasis in southwest of Iran. Alexandria J Med. 2019;53(1):93-8. https://doi.org/10.1016/j.ajme.2016.03.001.

  • 13.

    Saki J, Khademvatan S. A molecular study on cutaneous leishmaniasis lesions in Khuzestan province (South west of Iran). Jundishapur J Microbiol. 2011;4(4):283-8.

  • 14.

    Marfurt J, Nasereddin A, Niederwieser I, Jaffe CL, Beck HP, Felger I. Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis. J Clin Microbiol. 2003;41(7):3147-53. [PubMed ID: 12843055]. [PubMed Central ID: PMC165364]. https://doi.org/10.1128/jcm.41.7.3147-3153.2003.

  • 15.

    Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HD, Presber W, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis. 2003;47(1):349-58. [PubMed ID: 12967749]. https://doi.org/10.1016/s0732-8893(03)00093-2.

  • 16.

    Akhoundi M, Hajjaran H, Baghaei A, Mohebali M. Geographical distribution of leishmania species of human cutaneous leishmaniasis in Fars province, Southern Iran. Iran J Parasitol. 2013;8(1):85-91. [PubMed ID: 23682265]. [PubMed Central ID: PMC3655245].

  • 17.

    Behravan M, Moin-Vaziri V, Haghighi A, Rahbarian N, Taghipour N, Abadi A, et al. Molecular identification of Leishmania species in a re-emerged focus of Cutaneous Leishmaniasis in Varamin district, Iran. J Arthropod Borne Dis. 2017;11(1):124-31. [PubMed ID: 29026859]. [PubMed Central ID: PMC5629294].

  • 18.

    Hajjaran H, Vasigheh F, Mohebali M, Rezaei S, Mamishi S, Charedar S. Direct diagnosis of Leishmania species on serosity materials punctured from cutaneous leishmaniasis patients using PCR-RFLP. J Clin Lab Anal. 2011;25(1):20-4. [PubMed ID: 21254238]. https://doi.org/10.1002/jcla.20377.

  • 19.

    Hashemi N, Mohaghegh M, Hashemi M, Azami M, Mortazavidehkordi N, Hashemi C, et al. PCR-RFLP diagnosis and characterization of Leishmania species causing human cutaneous leishmaniasis and evaluation of treatment times with glucantime in these patients. Trop Biomed. 2016;33:689-96.

  • 20.

    Shiee MR, hajjaran H, Mohebali M, Doroodgar A, Hashemi Saadat M, Teimouri A, et al. A molecular and parasitological survey on cutaneous leishmaniasis patients from historical city of Kashan in Isfahan province, Center of Iran. Asian Pac J Trop Dis. 2012;2(6):421-5. https://doi.org/10.1016/s2222-1808(12)60093-0.

  • 21.

    Mohammadiha A, Dalimi A, Mahmoodi MR, Parian M, Pirestani M, Mohebali M. The PCR-RFLP-based detection and identification of the Leishmania species causing human cutaneous leishmaniasis in the Khorasan-Razavi province, Northeast of Iran. J Arthropod Borne Dis. 2017;11(3):383-92. [PubMed ID: 29322055]. [PubMed Central ID: PMC5758634].

  • 22.

    Mirzaie F, Eslami G, Yosefi MH, Pestehchian N. Molecular identification of Leishmania isolates obtained from patients suspected as having cutaneous leishmaniasis referred to reference laboratories from Yazd province in central Iran. Adv Biomed Res. 2013;2:92. [PubMed ID: 24524036]. [PubMed Central ID: PMC3908692]. https://doi.org/10.4103/2277-9175.122525.

  • 23.

    Mahmoudzadeh-Niknam H, Ajdary S, Riazi-Rad F, Mirzadegan E, Rezaeian A, Khaze V, et al. Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran. Trop Med Int Health. 2012;17(11):1335-44. [PubMed ID: 22947226]. https://doi.org/10.1111/j.1365-3156.2012.03078.x.

  • 24.

    Maraghi S, Samarbaf Zadeh A, Sarlak AA, Ghasemian M, Vazirianzadeh B. Identification of cutaneous leishmaniasis agents by nested po-lymerase chain reaction (Nested-PCR) in Shush city, Khuzestan province, Iran. Iran J Parasitol. 2007;2(3):13-5.

  • 25.

    Ghatee MA, Mirhendi H, Karamian M, Taylor WR, Sharifi I, Hosseinzadeh M, et al. Population structures of Leishmania infantum and Leishmania tropica the causative agents of kala-azar in Southwest Iran. Parasitol Res. 2018;117(11):3447-58. [PubMed ID: 30105405]. https://doi.org/10.1007/s00436-018-6041-1.

  • 26.

    Holakouie-Naieni K, Mostafavi E, Boloorani AD, Mohebali M, Pakzad R. Spatial modeling of cutaneous leishmaniasis in Iran from 1983 to 2013. Acta Trop. 2017;166:67-73. [PubMed ID: 27836499]. https://doi.org/10.1016/j.actatropica.2016.11.004.

  • 27.

    Nazari M, Nazari S, Hanafi-Bojd AA, Najafi A, Nazari S. Situation analysis of cutaneous leishmaniasis in an endemic area, south of Iran. Asian Pac J Trop Med. 2017;10(1):92-7. [PubMed ID: 28107873]. https://doi.org/10.1016/j.apjtm.2016.12.001.

  • 28.

    Tashakori M, Ajdary S, Kariminia A, Mahboudi F, Alimohammadian MH. Characterization of Leishmania species and L. major strains in different endemic areas of cutaneous leishmaniasis in Iran. Iran Biomed J. 2003;7(2):43-50.

  • 29.

    Mahnaz T, Al-Jawabreh A, Kuhls K, Schonian G. Multilocus microsatellite typing shows three different genetic clusters of Leishmania major in Iran. Microbes Infect. 2011;13(11):937-42. [PubMed ID: 21664984]. https://doi.org/10.1016/j.micinf.2011.05.005.

  • 30.

    Khademvatan S, Neisi N, Maraghi S, Saki J. Diagnosis and identification of Leishmania spp. from Giemsa-stained slides, by real-time PCR and melting curve analysis in South-west of Iran. Ann Trop Med Parasitol. 2011;105(8):559-65. [PubMed ID: 22325815]. [PubMed Central ID: PMC4089809]. https://doi.org/10.1179/2047773211Y.0000000014.

  • 31.

    Maraghi S, Mardanshah O, Rafiei A, Samarbafzadeh A, Vazirianzadeh B. Identification of cutaneous leishmaniasis agents in four geographical regions of Khuzestan province using nested PCR. Jundishapur J Microbiol. 2013;6(4). https://doi.org/10.5812/jjm.4866.